| Literature DB >> 24560667 |
Shuang Liu1, Li Lai2, Qiuhong Zuo2, Fujun Dai2, Lin Wu2, Yan Wang2, Qingxia Zhou2, Jian Liu3, Jiang Liu4, Lei Li2, Qingxiang Lin2, Chad J Creighton5, Myra Grace Costello3, Shixia Huang3, Caifeng Jia2, Lujian Liao2, Honglin Luo6, Junjiang Fu7, Mingyao Liu2, Zhengfang Yi8, Jianru Xiao9, Xiaotao Li10.
Abstract
The REGγ-proteasome serves as a short-cut for the destruction of certain intact mammalian proteins in the absence of ubiquitin- and ATP. The biological roles of the proteasome activator REGγ are not completely understood. Here we demonstrate that REGγ controls degradation of protein kinase A catalytic subunit-α (PKAca) both in primary human umbilical vein endothelial cells (HUVECs) and mouse embryonic fibroblast cells (MEFs). Accumulation of PKAca in REGγ-deficient HUVECs or MEFs results in phosphorylation and nuclear exclusion of the transcription factor FoxO1, indicating that REGγ is involved in preserving FoxO1 transcriptional activity. Consequently, VEGF-induced expression of the FoxO1 responsive genes, VCAM-1 and E-Selectin, was tightly controlled by REGγ in a PKA dependent manner. Functionally, REGγ is crucial for the migration of HUVECs. REGγ(-/-) mice display compromised VEGF-instigated neovascularization in cornea and aortic ring models. Implanted matrigel plugs containing VEGF in REGγ(-/-) mice induced fewer capillaries than in REGγ(+/+) littermates. Taken together, our study identifies REGγ as a novel angiogenic factor that plays an important role in VEGF-induced expression of VCAM-1 and E-Selectin by antagonizing PKA signaling. Identification of the REGγ-PKA-FoxO1 pathway in endothelial cells (ECs) provides another potential target for therapeutic intervention in vascular diseases.Entities:
Keywords: Angiogenesis; E-Selectin; FoxO1; PKAca; REGγ; VCAM-1
Mesh:
Substances:
Year: 2014 PMID: 24560667 PMCID: PMC4237316 DOI: 10.1016/j.yjmcc.2014.02.007
Source DB: PubMed Journal: J Mol Cell Cardiol ISSN: 0022-2828 Impact factor: 5.000